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Abstract
Background: Recurrent pregnancy loss (RPL) or recurrent spontaneous abortion is an obstetric complication that affects
couples at reproductive age. Previous reports documented a clear relationship between parents with chromosomal
abnormalities and both recurrent miscarriages and infertility. However, limited data is available from the Arabian
Peninsula which is known by higher rates of consanguineous marriages. The main goal of this study was to determine
the prevalence of chromosomal abnormalities and thrombophilic polymorphisms, and to correlate them with RPL and
consanguinity in Saudi Arabia.
Methods: Cytogenetic analysis of 171 consent patients with RPL was performed by the standard method of 72-h
lymphocyte culture and GTG banding. Allelic polymorphisms of three thrombophilic genes (Factor V Leiden,
Prothrombin A20210G, MTHFR C677T) were performed using PCR-RFLP (restriction fragment length polymorphism)
and gel electrophoresis.
Results: Data analysis revealed that 7.6 % of patients were carrier of numerical or structural chromosomal
abnormalities. A high rate of translocations (46 %) was associated to increased incidence of RPL. A significant
correlation between consanguineous RPL patients and chromosomal abnormalities (P < 0.05) was found. Both
Factor V Leiden and Prothrombin A20210G allelic polymorphisms were significantly associated with a higher
prevalence of RPL.
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Conclusions: This study demonstrated a strong association between RPL and the prevalence of chromosomal
abnormalities and inherited thrombophilia. Given the high rate of consanguineous marriages in the Saudi
population, these results underline the importance of systematic cytogenetic investigation and genetic counseling
preferably at the premarital stage or at least during early pregnancy phase through preimplantation genetic diagnosis
(PGD).
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Background
Recurrent miscarriages (RM) are clinically detectable
pregnancies that fail to progress. They are common
pregnancy complications that affects 15–20 % of couples
[1]. It is a common obstetric health concern that affects
around 5 % of women at the reproductive age [2, 3]. Re-
garding the RM etiology, it is due to several causes in-
cluding chromosomal, genetic, anatomic, immune and
infective factors [1]. Although it is still a controversy
whether RM is considered after 2 pregnancy losses ver-
sus 3 or more, most of clinicians recommended initiat-
ing evaluations from the onset of the second miscarriage
since there was no significant difference in RM suscepti-
bility between several patients with 2 versus 3 and more
pregnancy losses [4].
Despite worthy studies in Obstetrics/Gynecology clinics
and IVF (in vitro fertilization) centers worldwide of this
sporadic complication of early pregnancy, RM etiology re-
mains poorly understood [5, 6]. Therefore, effective diag-
nosis and prevention/treatment approaches are still
lacking [7, 8]. Several causes underlying this failure to de-
liver a normal and viable embryo were reported including
aged mothers, uterine abnormalities, placental abruption,
incompetent cervix, parents' chromosomal and genetic
background, immune disorders and/or endocrine imbal-
ances. Among these causes, three in particular were con-
sidered as the major factors of RM including: (i) structural
and numerical chromosomal abnormalities, (ii) inflamma-
tory and autoimmune disorders, and (iii) allelic polymor-
phisms of some pro-thrombophilic genes [6, 9–12]. In
fact, positive correlations were reported between chromo-
somal abnormalities in the embryos and higher RM [13].
This fetal genomic incompatibility to life was associated to
chromosomal aneuploidies and mosaicism within the
embryo/abortus [14–17]. Moreover, couples who carry
chromosomal abnormalities were found to be at risk for
repeated miscarriages and therefore have lower chances to
deliver a viable offspring [7, 18–21]. Spontaneous miscar-
riages caused by the chromosomal abnormalities may
arise from one of the parents producing defective gametes
that will lead to fetal abnormalities and mental disorders.
In fact, 3–6 % of RM were due to chromosomal abnor-
malities of one of the two partners [22–24]. Trisomies in
chromosomes 13–16, 21 and 22 were the most common
chromosomal aneuploidies followed by monosomy X
(45, X). Thus, parental karyotyping is a recommended
procedure to assess the cause of recurrent pregnancy
losses [23, 25–27].
Pro-thrombophilic factors have also been suggested as
one of the major causes of RM. In fact, some genetic
polymorphisms of prothrombin (FII G 20210A), Factor
V (Factor V Leiden, FVL) and methylene tetrahydrofolate
reductase (MTHFR, C677T gene variant) genes were
strongly associated with recurrent miscarriages [3, 28, 29].
These factors of inherited thrombophilia disturb normal
placental vascularization and formation leading to fetal
growth restrictions, pregnancy failure, placental abruption
and therefore miscarriages or stillbirth [30].
In addition to the RM incidence worldwide, Saudi
Arabia is well known by a high level of consanguineous
marriages driven by ethnic or tribal considerations [31].
These consanguineous marriages significantly increase the
incidence of inherited recessive disorders and affect some
reproductive and developmental health parameters such as
infertility rates, recurrent miscarriages, and congenital disor-
ders (e.g. thrombophilia) [32–35]. The objective of this study
is to assess possible correlations between chromosomal ab-
normalities and couples with history of RM. Additional in-
vestigations were also carried out to assess the presence of
some thrombophilia genetic risk factors including factor V
Leiden, Prothrombin A20210G, MTHFR C677T mutations
that may further explain the RM outcomes.
Methods
Study approach
A cohort of patients with a history of two or more miscar-
riages up to 20 weeks was conducted at King Abdulaziz
University Hospital in the Western region of Saudi Arabia
between 2008 and 2013. This study included couples with
repeated pregnancy losses who had presented themselves
during this period for further investigations. Pregnancy
was confirmed by a positive human chorionic gonado-
tropin (HCG) test using serum or urine in combination
with ultrasounds.
Patients
Following King Abdulaziz University board approval and
informed consent of the patients, a cohort of 171 RM
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patients (73 couples in addition to 25 women only be-
cause their husbands were not available for cytogenetic
analysis) were selected for peripheral blood collection
and a detailed counseling questionnaire covering their
personal details, family history and any laboratory results
or past investigations that had been conducted. Only
patients who experienced two or more miscarriages up
to 20 weeks of gestational age were included in this
study. Patients’ anonymity and data confidentiality were
preserved.
Cytogenetic analysis
The peripheral blood of each patient (5–10 ml) was sub-
jected to standard 72-h lymphocyte culture to produce
Metaphases for cytogenetic analysis (karyotyping) using
standard harvesting protocols. GTG banding (G banding)
was performed by a pretreatment of chromosomes with
trypsin followed by Giemsa staining. Chromosomes’ ana-
lysis was done using Cytovision software, a semi-automatic
Applied Imaging Karyotyper, and karyotypes were designed
according to International System for Human Cytogenetic
Nomenclature [36]. Karyotype analysis was performed
using at least 20 cells for each patient. In case of suspected
mosaicism, this number was expanded to 100 metaphases.
Genetic risk factors causing thrombophilia
Since associations between thromphobilia and RM were
previously reported [37, 38], we proposed in this study
to further explore the thrombophilic genetic polymor-
phisms in our patients’ cohort. The main genes investigated
using PCR- RFLP (restriction fragment length polymorph-
ism) were Factor V Leiden (FVL), Prothrombin A20210G
and MTHFR C677T. Briefly and following DNA extraction
(QIAamp DNA Blood Maxi kit, Qiagen), a Taq-polymerase
based PCR using specific primers for each gene was per-
formed (Table 1). The PCR product for each gene is then
fragmented using a specific restriction enzyme in order to
target potential Single Nucleotide Polymorphisms (SNPs)
and separated according to their base pairs’ size by gel elec-
trophoresis as summarized in Table 1.
Statistical analysis
Association between the patients’ clinical features and the
cytogenetic analysis in the cohort of patients were
assessed using χ2 analysis and Fisher’s exact test. The stat-
istical analysis was carried out using MATLAB R2012a
(Version 7.14; The MathWorks, Natick, MA, USA).
Results
Patients’ cohort and RM
This study reported the chromosomal analysis of the
171 RM patients (73 couples + 25 women). There were
492 documented pregnancies in this cohort (mean preg-
nancy per couple = 5.02, SD = 2.79). The age of the subjects
ranged from 18 to 48 (mean 32.17, SD = 6.39) (Table 2)
and number of miscarriages were between 2 to 14 (mean
miscarriage per couple = 4.18; SD = 2.578). Out of 98
women, 32 were able to achieve successful pregnancies
which led to viable baby, whereas the remaining 67.35 %
were unable to achieve any successful full term pregnancy
despite several attempts. Overall, most of clinical pregnan-
cies (79.59 %) were terminated in their first trimester while
only 12.24 % and 8.16 % ended up respectively at the sec-
ond and third trimesters.
Chromosomal analysis
Following cytogenetic analysis, 13 patients were found
to be carrier of chromosomal abnormalities and/or poly-
morphisms (7.6 %), 10 of them were women (77 %) and
3 (23 %) were men. The prevalence of mosaicism, bal-
anced translocations, duplications, Robertson transloca-
tion, triple X syndrome, and allelic polymorphism were
2.34 %, 1.17 %, 1.17 %, 0.58 %, 0.58 % and 1.17 % respect-
ively. Very surprisingly in this study, the majority of young
women (≤35 years) (78.6 %) were carriers of chromosomal
aberrations and have a high average of pregnancy failures
(Table 3).
Around 30 % of couples in this patients’ cohort had a
family history of consanguineous marriages. Interestingly,
a significant positive correlation (P = 0.046) between con-
sanguineous marriages and chromosomal abnormalities
Table 1 Specific primers sequences, restriction enzymes and restriction digestion products’ sizes for FVL, Prothrombin A20210G and
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was recorded. However, correlation between the number
of miscarriages and consanguinity was not statistically sig-
nificant (Table 4). A relatively higher number of spontan-
eous miscarriages in couples with abnormal karyotype
(mean 4.78, SD = 3.11) was observed when compared to
those with normal karyotype (mean 4.12, SD = 2.57). Out
of 52 pregnancies attempts performed by just 9 couples
with chromosomal abnormalities, only 9 (17 %) ended up
with live birth.
Thrombophilia allelic polymorphisms and RM
Results of SNPs analysis of 3 thrombophilic genes
showed that the frequencies of FV Leiden, Prothrombin
and MTHFR mutations among RM patients compared
to general incidence reported in Saudi population. Al-
lelic polymorphisms of mainly for FVL and Prothrombin
genes were relatively high supporting thus our hypoth-
esis of considering these as RM genetic factors (Table 5).
Discussions
Recurrent miscarriages are clinically detectable pregnan-
cies that fail to progress due to several causes including
chromosomal, genetic, anatomic, immune or infective
factors [1]. Chromosomal and genetic abnormalities are
among the most common factors leading to recurrent
miscarriages and pregnancy demise [23, 39, 40]. Amongst
these genetic factors, thrombophilia was shown to be a
main cause leading to recurrent miscarriages [3, 29].
Moreover, Saudi population is marked by a high rate of
consanguineous marriages (about 58 %), the majority of
them were between first-degree cousins [33, 34]. In this
particular context, the current study was designed to
assess two major parameters know to be causative of
RM: (i) the chromosomal abnormalities; and (ii) inher-
ited thrombophilia.
Chromosomal abnormalities analysis
Following cytogenetic analysis of our patients' cohort,
77 % of carriers of numerical or chromosomal abnormal-
ities were women. It means that a high female to male ratio
of 4: 1 in couples carriers of chromosomal abnormalities
was recorded, which is higher than previously re-
ported ratios (around 2:1) in Saudi Arabia and elsewhere
[18, 41, 42]. This higher ratio in women facing recurrent
miscarriages could be explained by the heavy involvement
of their oocytes in the fertilization process and early em-
bryo development by providing all the molecular machin-
ery of the new embryo start-up and early development
[43–45]. Therefore, these molecular or cytogenetic imbal-
ances look to affect the onset and/or the stability of the
Table 2 Summary of RM patients’ cohort age range, gender and chromosomal abnormalities incidence
Total RM patients Women Men Chromosomal abnormalities
No. of cases 171 98 73 13 (7.6 %)
Age range (years) 18 – 48 18 -47 24-48 23-34
Mean 32.17 29.98 35.45 30.50
Std Deviation 6.39 5.98 5.57 4.17
Missing data (%) 16 (9.36 %) 5 (2.92 %) 11 (6.43 %) 1 (0.58 %)
Table 3 Cytogenetic results, number of miscarriages and age of RM patients with numerical and/or structural chromosomal
abnormalities
No. Sex Age Graviditya Parityb Abortusc Karyotype
1 F 30 8 3 5 45,XX,rob(14:21)(q11.1;q11.1)
2 F 23 2 0 2 46,XX,dup(1)(q11q21)
3 F 34 3 0 3 46,XX,dup(1)(q11q21)
4 F 33 9 2 7 46, XX,t(3;7) (p23;p22)
5 F 28 6 2 4 46,XX[97]/47,XX,+mar[3]
6 M 33 // // // 46,XY[76]/47,XY,+mar[4]
7 F 34 4 2 2 46,XX[96]/45,XO[4]
8 M 32 // // // 46,XY, add(Y)(p11.3)
9 F 34 4 0 4 46,XX[96]/45,X[2]/37-42,XX,-X,t(7;14) (q34;p10) + mer(cp2)
10 F 24 4 0 4 47,XXX
11 M - 12 0 12 46,XY,t(3;4;13;6)(q25;q32;q31;q22)
12 F 35 12 0 11 46,XX,13 ps + (polymorphism)
13 F 34 8 2 6 46,XX,16qh + (polymorphism)
aGravidity = No. of pregnancies; bParity = No. of full term pregnancies; cAbortus = No. of terminated pregnancies
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pregnancy with higher incidence in women compared to
men. These findings are in line with previous reports de-
scribing associations between the maternal chromosomal
status and RM [46, 47].
Among the carriers’ cohort, more than 46 % of pa-
tients showed various types of translocations. This is
consistent with previous reports where chromosomal ab-
errations, mainly translocations in the parents or the
abortus (embryo), were shown to be strongly associated
with higher incidence of miscarriages [15, 46, 48–52].
The presence of chromosomal polymorphisms were
associated with abnormalities of the heterochromatin
constitutively located in different loci of the chromo-
somes and might be associated with some diseases as in-
fertility and RM [53–55].
Turner Syndrome (TS) is another chromosomal disor-
ders reported in our patients’ cohort (Fig. 1) which usu-
ally is marked by a total or partial loss of one of the two
X chromosomes. In fact, recurrent miscarriages, fetal
perinatal death or malformed newborns are known to be
frequent in TS patients [56–58]. Our data also confirm
this strong association between women with TS and RM
although the number of patients carrying this syndrome
is not as expected in our cohort, since patients with TS
are known to face RM and are not routinely referred for
that. Concomitant with our results, other chromosomal
disorders, including duplications and deletions have
been also reported in RM couples [17, 59].
Age, consanguinity and RM
The age range of the patients’ group involved in this
study was wide (from 18 to 48) (Table 2). One striking
finding is that the ages of all of the 13 patients (100 %)
identified as carriers of chromosomal abnormalities were
below 35 years (Table 3). Despite their relative young
age of marriage, these couples were struggling to conceive
since they (both or one of them) are carrier of chromo-
somal abnormalities leading to higher risk of repeated
miscarriages and lower chances to deliver a viable and
healthy offspring [18, 19]. These patients are also facing
an important social pressure to procreate [60] especially
in conservative societies as Saudi Arabia. Such particular
context may explain the high average (≈5) of pregnancy
attempts per couple even at relatively young age. Such so-
cial pressure to procreate is very interesting to highlight
compared to other societies where the childfree is one of
the new reproductive lifestyle trends [60, 61]. However,
the high incidence of population inbreeding and consan-
guineous marriages could explain the high rate of RM at
this early age [31, 62]. In fact, around one third of the cou-
ples involved in this study were consanguineous (Table 4).
Although it is somehow decreasing, this consanguinity
driven by an old Arabic tradition is known to rise the
frequency of recessive genetic diseases as well as repro-
ductive and developmental disorders such as infertility
rates, recurrent miscarriages, and congenital disorders
(e.g. thrombophilia) [32–35]. A significant positive cor-
relation between consanguinity and reported chromo-
somal aberrations and polymorphic variants (P = 0.046)
documented in this study supports that the RM is
mainly due to genomic instability manifested in several
chromosomal abnormalities in this group (age ≤ 35) ra-
ther than reproductive aging or other known factors.
On the other hand, no significant correlation between
the number of RM and consanguinity was reported. This
result might be explained by the fact that the consanguin-
ity negative effect is observed mainly in the presence of






Male 70 3 0.356
Female 90 8
Miscarriage stage
Trimester 1 68 10 0.452
Trimester 2 or 3 19 01
Miscarriage frequency
≤ 3 49 4 0.339
> 3 40 7
Type of marriage
Consanguineous 51 7 0.046*
Non-consanguineous 109 4
Citizenship
Saudi 117 6 0.295
Non Saudi 43 5
*Significant Fisher exact test (α = 0.05)
Table 5 Prevalence of FV Leiden, Prothrombin and MTHFR mutations among RM patients
Gene Prevalence in RM patients Prevalence reported in others
studies in Saudi Arabia (%)cHeterozygous (%) Homozygous (%) Total (%)
FVL 14.92 0.58 15.5a 1.3
Prothrombin A20210G 6 - 6a 0.7
MTHFR C677T 23.75 1.75 25.5b 2.5
aSignificant (P < 0.05); bnot significant (P > 0.05); c[68]
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carried chromosomal and/or genetic abnormalities in one
or both partners, and only very large cohorts of patients
might detect such impact.
However, the aging process seems to be the main cause
of RM in couples beyond 35 years since no chromosomal
disorders have been detected. In fact, the miscarriage
frequency and subsequent reproductive failure were
positively correlated to the increase of paternal and/or
maternal age [63–65]. Such aging process (beyond 35
and 40 years respectively for women and men) is known
to cause genetic and chromosomal disorders during
gametogenesis, fertilization and early embryonic devel-
opment [15, 46, 65]. Such fetal genetic alterations in-
duce a genomic instability and therefore RM.
Out of 52 pregnancies among couples carrying chromo-
somal abnormalities, only 17 ended up with live birth.
This rate is lower than that reported in other studies
which showed up to 45 % live birth among couples with
structural chromosomal abnormalities. This could be ex-
plained by predisposition of the Saudi society to other RM
risk factors as thrombophilia [35, 66].
Thrombophilia genetic polymorphisms and RM
Coagulation anomalies are reported to induce import-
ant pregnancy complications. In this context, pro-
thrombophilic factors were reported to be involved in
RM including FVL, Prothrombin A20210G and MTHFR
C677T. These factors are known to disrupt key events as-
sociated to placentation, fetal development and pregnancy
progression till the delivery [3, 28–30, 67]. In this study,
PCR- RFLP was used for molecular analysis of potential
SNPs in three (3) thrombophilia-associated genes: FVL,
Prothrombin A20210G and MTHFR C677T as detailed in
Table 1. The screening for potential SNPs in these 3 genes
showed that the frequencies of FVL, Prothrombin and
MTHFR mutations (including both homozygous and car-
riers) were respectively 15.5 %, 6 % and 25.5 (Table 5).
These results confirm the atypical and relatively high inci-
dence of thrombophilic gene polymorphisms among Saudi
population reported in previous studies [68]. Beside na-
tional awareness campaigns, these findings support more
preventive measurements to be considered at the premari-
tal and/or before the IVF procedures in ART clinics.
The prevalence of FVL and Prothrombin A20210G
mutations reported in patients’ cohort support a strong
relationship between these traits and RM. Following
analysis of the most important studies about inherited
thrombophilia, our data are in line with previous findings
where both mutations have been known as common
genetic disorders that predispose to early and late RM
[3, 29, 69–71]. A recent study in Saudi Arabia also con-
firmed the involvement of mutations in these two par-
ticular genes (FVL and Prothrombin A20210G) in
increasing RM incidence [72]. Additionally, these two
thrombophilic genetic traits were associated with ob-
stetric complications including miscarriages, placental
abruption, intrauterine growth retardation (IUGR) or
death [69, 73–75]. These findings explain the significant
correlations with RM reported in this study and support
the assumption that both factor V Leiden and Prothrom-
bin mutations are major risk factors for RM. Suitable
treatment of inherited and acquired thrombophilia will
improve the pregnancy outcomes as discussed elsewhere
[69]. Therefore, a national medical program for routine
screening of these two genes in patients with repeated
pregnancy failure in Saudi Arabia is highly recommended.
For MTHFR C677T mutation in RM patients and in
agreement with other studies, no significant (P > 0.05) as-
sociation with RM were found [29]. The general practice
of folic acid supplementation during pregnancy seems to
be the reason of masking the effect of the MTHFR muta-
tion in RM patients as reported elsewhere [76].
Since RM is a challenging obstetric complication with
various psychological, societal and economic burdens on
both couples and the health care system in general, our
study contributed to report an effect of both structural
and numerical effects of chromosomal abnormalities on
RM, which were amplified by consanguinity mainly for
couples under 35 years. Moreover, thrombophilic polymor-
phisms of FVL and Prothrombin A20210G were signifi-
cantly associated to higher prevalence of RM.
Conclusions
This study demonstrated a strong association between
RPL and the prevalence of chromosomal abnormalities
Fig. 1 Incidence of numerical and structural chromosomal
rearrangements in patients with RM (%). (D): duplications; (A):
Additions; (RT): Robertsonian Translocations; (BT): Balanced
Translocations; (CT): Complex Translocations; (TS): Turner Syndrome;
(CP) Chromosomal Polymorphisms; (SMC): Supernumerary
Marker Chromosomes
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and inherited thrombophilia and confirms the high inci-
dence of RM in the Western region of Saudi Arabia sug-
gesting thus some main but non-exclusive causes of this
disease. Our findings lay also foundation for larger
cohort-based studies to further validate and confirm the
impact of thalassemia gene polymorphisms and hemo-
globinopathies in general, chromosomal aberrations and
consanguinity, but also to predict the involvement of
other anatomic, endocrine or auto-immune factors.
Our study highlights the importance of including cyto-
genetic and thrombophilia testing as part of the routine
clinical investigation of RM and during Preimplantation
Genetic Screening (PGS) in IVF clinics in order to sug-
gest suitable management and/or treatment approaches.
Such genetic testing along with standard karyotyping are
highly recommended to be included in premarital test
especially for consanguineous partners. In the genomic
era, further studies focusing on the molecular mechanism
of thrombophlic polymorphisms on placental pathologies
and pregnancy loss using high-throughput technologies
as array Comparative Genomic Hybridization (aCGH)
and Next Generation Sequencing (NGS) are highly rec-
ommended. We believe that a multidisciplinary and col-
laborative approach between obstetricians, geneticists,
hematologists, scientists and bioethicists combined with
effective awareness program will contribute to relieve the
burden of RM.
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